State-selective modulation of heterotrimeric Gαs signaling with macrocyclic peptides
暂无分享,去创建一个
K. Shokat | M. von Zastrow | Ziyang Zhang | Shizhong A. Dai | H. Suga | Rong Gao | Qi Hu | E. Blythe | H. Peacock
[1] Anthony Leyme,et al. Revealing the Activity of Trimeric G-proteins in Live Cells with a Versatile Biosensor Design , 2020, Cell.
[2] John D. McCorvy,et al. “TRUPATH, an Open-Source Biosensor Platform for Interrogating the GPCR Transducerome” , 2020, Nature Chemical Biology.
[3] Catrin Sohrabi,et al. Methods for generating and screening libraries of genetically encoded cyclic peptides in drug discovery , 2020, Nature Reviews Chemistry.
[4] J. Fernandez-Banet,et al. The KRASG12C Inhibitor, MRTX849, Provides Insight Toward Therapeutic Susceptibility of KRAS Mutant Cancers in Mouse Models and Patients. , 2019, Cancer discovery.
[5] J. Desai,et al. The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity , 2019, Nature.
[6] Johanna K. S. Tiemann,et al. Structural Insights into the Process of GPCR-G Protein Complex Formation , 2019, Cell.
[7] D. Pei,et al. Understanding Cell Penetration of Cyclic Peptides. , 2019, Chemical reviews.
[8] R. MacKinnon,et al. Molecular basis of signaling specificity between GIRK channels and GPCRs , 2018, eLife.
[9] Joshua A. Kritzer,et al. Cell Penetration Profiling Using the Chloroalkane Penetration Assay. , 2018, Journal of the American Chemical Society.
[10] W. Weis,et al. The Molecular Basis of G Protein-Coupled Receptor Activation. , 2018, Annual review of biochemistry.
[11] P. Stewart,et al. Targeting G protein-coupled receptor signaling at the G protein level with a selective nanobody inhibitor , 2018, Nature Communications.
[12] K. Shokat,et al. Disease-Causing Mutations in the G Protein Gαs Subvert the Roles of GDP and GTP , 2018, Cell.
[13] D. Alessi,et al. LRRK2 kinase in Parkinson's disease , 2018, Science.
[14] Xiao-Feng Xiong,et al. Structure–Activity Relationship Studies of the Cyclic Depsipeptide Natural Product YM‐254890, Targeting the Gq Protein , 2017, ChemMedChem.
[15] J. Aoki,et al. Purinergic Receptor Transactivation by the β2-Adrenergic Receptor Increases Intracellular Ca2+ in Nonexcitable Cells , 2017, Molecular Pharmacology.
[16] I. Kufareva,et al. The GAPs, GEFs, GDIs and…now, GEMs: New kids on the heterotrimeric G protein signaling block , 2017, Cell cycle.
[17] Hiroaki Suga,et al. A RaPID way to discover nonstandard macrocyclic peptide modulators of drug targets. , 2017, Chemical communications.
[18] J. Steyaert,et al. Nanobodies to Study G Protein-Coupled Receptor Structure and Function. , 2017, Annual review of pharmacology and toxicology.
[19] D. Gloriam,et al. Total synthesis and structure-activity relationship studies of a series of selective G protein inhibitors. , 2016, Nature chemistry.
[20] R. Dey,et al. Regulation, Signaling, and Physiological Functions of G-Proteins. , 2016, Journal of molecular biology.
[21] J. Tesmer,et al. Structure of the Regulator of G Protein Signaling 8 (RGS8)-G alpha q Complex: MOLECULAR BASIS FOR G alpha SELECTIVITY. , 2016 .
[22] J. Tesmer,et al. Structure of the Regulator of G Protein Signaling 8 (RGS8)-Gαq Complex , 2016, The Journal of Biological Chemistry.
[23] Ron O. Dror,et al. Structural basis for nucleotide exchange in heterotrimeric G proteins , 2015, Science.
[24] P. Little,et al. Total synthesis of the cyclic depsipeptide YM-280193, a platelet aggregation inhibitor. , 2015, Organic letters.
[25] P. Lockhart,et al. Mutations in RAB39B cause X-linked intellectual disability and early-onset Parkinson disease with α-synuclein pathology. , 2014, American journal of human genetics.
[26] S. Sagan,et al. Cell‐penetrating peptides: 20 years later, where do we stand? , 2013, FEBS letters.
[27] S. Seshagiri,et al. The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer , 2013, Nature Reviews Cancer.
[28] Carla Mattos,et al. A comprehensive survey of Ras mutations in cancer. , 2012, Cancer research.
[29] Yuuki Hayashi,et al. Discovery of macrocyclic peptides armed with a mechanism-based warhead: isoform-selective inhibition of human deacetylase SIRT2. , 2012, Angewandte Chemie.
[30] T. Katoh,et al. Natural product-like macrocyclic N-methyl-peptide inhibitors against a ubiquitin ligase uncovered from a ribosome-expressed de novo library. , 2011, Chemistry & biology.
[31] S. Rasmussen,et al. Crystal Structure of the β2Adrenergic Receptor-Gs protein complex , 2011, Nature.
[32] T. Katoh,et al. Flexizymes for genetic code reprogramming , 2011, Nature Protocols.
[33] T. Corson,et al. Small-Molecule Hydrophobic Tagging Induced Degradation of HaloTag Fusion Proteins , 2011, Nature Chemical Biology.
[34] Randy J. Read,et al. Overview of the CCP4 suite and current developments , 2011, Acta crystallographica. Section D, Biological crystallography.
[35] T. Hakoshima,et al. Structural basis for the specific inhibition of heterotrimeric Gq protein by a small molecule , 2010, Proceedings of the National Academy of Sciences.
[36] P. Emsley,et al. Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.
[37] Shahab M. Danesh,et al. Recognition of the activated states of Galpha13 by the rgRGS domain of PDZRhoGEF. , 2008, Structure.
[38] Hiroshi Murakami,et al. Structural basis of specific tRNA aminoacylation by a small in vitro selected ribozyme , 2008, Nature.
[39] R. Roberts,et al. Evolution of class-specific peptides targeting a hot spot of the Galphas subunit. , 2008, Journal of molecular biology.
[40] Randy J. Read,et al. Phaser crystallographic software , 2007, Journal of applied crystallography.
[41] L. Jan,et al. Turning G proteins on and off using peptide ligands. , 2006, ACS chemical biology.
[42] Brian Kuhlman,et al. Minimal determinants for binding activated G alpha from the structure of a G alpha(i1)-peptide dimer. , 2006, Biochemistry.
[43] Hiroshi Murakami,et al. A highly flexible tRNA acylation method for non-natural polypeptide synthesis , 2006, Nature Methods.
[44] Alan V. Smrcka,et al. Differential Targeting of Gßγ-Subunit Signaling with Small Molecules , 2006, Science.
[45] Douglas M. Yau,et al. A new approach to producing functional G alpha subunits yields the activated and deactivated structures of G alpha(12/13) proteins. , 2006, Biochemistry.
[46] T. Kozasa,et al. Snapshot of Activated G Proteins at the Membrane: The Gαq-GRK2-Gßγ Complex , 2005, Science.
[47] Christopher A. Johnston,et al. A bifunctional Gαi/Gαs modulatory peptide that attenuates adenylyl cyclase activity , 2005 .
[48] T. K. Harden,et al. Structure of Gαi1 Bound to a GDP-Selective Peptide Provides Insight into Guanine Nucleotide Exchange , 2005 .
[49] S. Sprang,et al. Structure of the p115RhoGEF rgRGS domain–Gα13/i1 chimera complex suggests convergent evolution of a GTPase activator , 2005, Nature Structural &Molecular Biology.
[50] M. Taniguchi,et al. A Novel Gαq/11-selective Inhibitor* , 2004, Journal of Biological Chemistry.
[51] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[52] H. Murakami,et al. Designer ribozymes: programming the tRNA specificity into flexizyme. , 2004, Journal of the American Chemical Society.
[53] Richard W Roberts,et al. In vitro selection of state-specific peptide modulators of G protein signaling using mRNA display. , 2004, Biochemistry.
[54] H. Murakami,et al. A versatile tRNA aminoacylation catalyst based on RNA. , 2003, Chemistry & biology.
[55] Wei He,et al. Structural determinants for regulation of phosphodiesterase by a G protein at 2.0 Å , 2001, Nature.
[56] B. Kobilka,et al. Different effects of Gsalpha splice variants on beta2-adrenoreceptor-mediated signaling. The Beta2-adrenoreceptor coupled to the long splice variant of Gsalpha has properties of a constitutively active receptor. , 1998, The Journal of biological chemistry.
[57] S. Sprang,et al. Crystal structure of the adenylyl cyclase activator Gsalpha. , 1997, Science.
[58] S R Sprang,et al. Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS. , 1997, Science.
[59] S. Sprang,et al. The structure of the G protein heterotrimer Giα1 β 1 γ 2 , 1995, Cell.
[60] Heidi E. Hamm,et al. Structural determinants for activation of the α-subunit of a heterotrimeric G protein , 1994, Nature.
[61] H. Bourne,et al. Increased mitogenic responsiveness of Swiss 3T3 cells expressing constitutively active Gs alpha. , 1990, Biochemical and biophysical research communications.
[62] H. Bourne,et al. Cholera toxin induces cAMP-independent degradation of Gs. , 1989, The Journal of biological chemistry.
[63] Douglas M. Yau,et al. A New Approach to Producing Functional G α Subunits Yields the Activated and Deactivated Structures of G α 12/13 Proteins , 2009 .
[64] R. Roberts,et al. Evolution of Class-Specific Peptides Targeting a Hot Spot of the G α s Subunit , 2008 .
[65] Vincent B. Chen,et al. Acta Crystallographica Section D Biological , 2001 .
[66] Z. Otwinowski,et al. Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[67] Z. Otwinowski,et al. [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[68] S. Sprang,et al. Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS. , 1997, Science.
[69] S. Sprang,et al. The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2. , 1995, Cell.
[70] H. Hamm,et al. Structural determinants for activation of the alpha-subunit of a heterotrimeric G protein. , 1994, Nature.